Nexthera Capital Lp adds Lannett Company (LCI) to its portfolio

Lannett Company (LCI) : Nexthera Capital Lp added new position in Lannett Company during the most recent quarter end. The investment management firm now holds 150,000 shares of Lannett Company which is valued at $4,704,000 , the company said in a statement filed on Aug 15, 2016 with the SEC.Lannett Company makes up approximately 4.60% of Nexthera Capital Lp’s portfolio.

Other Hedge Funds, Including , Invictus Rg Pte. Ltd. sold out all of its stake in LCI during the most recent quarter. The investment firm sold 1,816 shares of LCI which is valued $56,950. Renaissance Technologies sold out all of its stake in LCI during the most recent quarter. The investment firm sold 21,500 shares of LCI which is valued $674,240. Nine Chapters Capital Management sold out all of its stake in LCI during the most recent quarter. The investment firm sold 76,900 shares of LCI which is valued $2,486,177. Tci Wealth Advisors added LCI to its portfolio by purchasing 59 company shares during the most recent quarter which is valued at $1,870.Louisiana State Employees Retirement System boosted its stake in LCI in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 12,400 shares of Lannett Company which is valued at $388,120. Lannett Company makes up approx 0.02% of Louisiana State Employees Retirement System’s portfolio.

Lannett Company closed down -0.49 points or -1.45% at $33.37 with 6,96,241 shares getting traded on Thursday. Post opening the session at $33.71, the shares hit an intraday low of $33.15 and an intraday high of $34.3664 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Lannett Company reported $0.73 EPS for the quarter, beating the analyst consensus estimate by $ 0.13 according to the earnings call on Aug 23, 2016. Analyst had a consensus of $0.60. The company had revenue of $168.90 million for the quarter, compared to analysts expectations of $161.56 million. The company’s revenue was up 70.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 EPS.

Many Wall Street Analysts have commented on Lannett Company. Deutsche Bank Initiated Lannett Company on Jun 29, 2016 to “Hold”, Price Target of the shares are set at $26.

Lannett Company Inc. develops manufactures markets and distributes generic versions of brand pharmaceutical products. The Company’s products include Levothyroxine Sodium tablets Digoxin tablets Butalbital products Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products such as Cocaine Topical Solution (C-Topical) Morphine Sulfate Oral Solution Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Lannett Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Lannett Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.